Do we need a feminist global health policy to spur women’s health innovation? Part 2: Drug drought in Women’s Health

Day 3- Current Challenge 2

Day2 Migration – CC 2

Wednesday, May 29, 2024

11:00 am - 12:30 pm

Event description

In the realm of global health policy and research, persistent and historical gender biases continue to permeate a largely patriarchal ecosystem. These biases result in the oversight of crucial gender dimensions and disadvantage women’s health, hindering adequate investment and innovation tailored to address women’s unique and diverse health needs.
Despite growing awareness of these biases and increased efforts by civil society, academia, and the philanthropic sector (such as the White House Initiative on Women’s Health Research, and the Women’s Health Innovation Opportunity Map by NIH and the Bill & Melinda Gates Foundation) to spur gender responsive and inclusive research and innovation to advance women’s health, progress remains slow and fragmented.
In two sessions, we will delve into the landscape of women’s health research and development (R&D), examining the existing barriers and disparities through a gender lens. Our conversation aims to connect the dots between persistent gender biases in research and the transformative potential of a feminist global health policy (FGHP). By shining a spotlight on the barriers and obstacles in advancing women’s health R&D, we seek to explore whether a FGHP holds the potential to accelerate the discovery and enhance the accessibility of new innovations, crucial to interrupting the prevailing health inequities, particularly those that disproportionately affect women.
Part 2 ‘Drug drought in Women’s Health’ aims to discuss gaps and strengths of the women’s health R&D landscape in the last 20 year. Together with our distinguished panel of diverse stakeholders, we will discuss where the need for innovation is, and how the future of women’s health R&D looks like. In continuation with part 1, the discussion will also include valuable recommendations to spur innovation and advance women’s health in all its diversities.

The objectives of this session :

  • Examine gender-related barriers and gender disparities in women’s health research and development, identifying challenges hindering innovation.
  • Explore the potential impact of a Feminist Global Health Policy in accelerating the discovery and accessibility of innovative solutions to address health inequities for women.


Speakers will be announced soon

Ahmet Metin Gülmezoglu

Switzerland, Speaker
Concept Foundation

Anne Ammerdorffer

Switzerland, Speaker
Concept Foundation

Lindsay Keir

United Kingdom, Speaker
Policy Cures Research

Edith Roset Bahmanyar

Switzerland, Speaker

Martina Penazzato

Switzerland, Speaker
World Health Organization

Sabrina Badir

Switzerland, Speaker
Pregnolia AG

Temitayo Erogbogbo

Switzerland, Speaker
MSD for Mothers

Dr Lindsay Keir

Speaker, Policy Cures Research

Edith Roset Bahmanyar

Speaker, Organon

Martina Penazzato

Speaker, World Health Organization

Notes to participants


Register for the event

Geneva Health Forum logo


Geneva Health Forum

About the Geneva Health Forum

Established in 2006 by the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE), the Geneva Health Forum (GHF) is a Swiss not-for-profit initiative that brings together a diverse range of stakeholders to discuss and address global health challenges.

The GHF plays a pivotal role in the global health landscape, as a neutral and inclusive platform, fostering dialogue and collaboration among key players in the field, including policymakers, representatives from academia, civil society, and the private sector.

Its core mission is to facilitate constructive dialogue among these global health actors, which, in turn, contributes to the improvement of health policies and access to care worldwide. The Geneva Health Forum proudly collaborates with some of the most prominent international organizations based in Geneva.